Browsing NTNU Open by Author "Mørk, Erik"
Now showing items 1-4 of 4
-
Aspects of selection and treatment of basal cell carcinoma for photodynamic therapy
Mørk, Erik (Doctoral theses at NTNU;2024:238, Doctoral thesis, 2024) -
Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic Therapy
Mørk, Erik; Mjønes, Patricia Gjertrud; Foss, Olav A.; Mørk, Cato; Bachmann, Ingeborg Margrethe; Kroon, Susanne; Dotterud, Lars Kåre; Helsing, Per; Vatne, Øystein; Christensen, Eidi (Journal article; Peer reviewed, 2024)Photodynamic therapy is an approved treatment for primary, superficial, and small nodular basal cell carcinomas with a thickness of < 2 mm located on low-risk sites. Histologically verified basal cell carcinomas clinically ... -
Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy outcome
Mørk, Erik; Mjønes, Patricia Gjertrud; Foss, Olav A.; Bachmann, Ingeborg Margrethe; Christensen, Eidi (Peer reviewed; Journal article, 2023)Photodynamic therapy (PDT) is an effective and cosmetically beneficial treatment of low-risk basal cell carcinomas (BCCs). To optimize PDT response, it is important to correctly select tumors. We sought to find markers ... -
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre study
Christensen, Eidi; Mørk, Erik; Foss, Olav Andreas; Mørk, Cato; Kroon, Susanne; Dotterud, Lars Kåre; Helsing, Per; Vatne, Øystein; Skogvoll, Eirik; Mjønes, Patricia Gjertrud; Bachmann, Ingeborg Margrethe (Peer reviewed; Journal article, 2024)Background Topical photodynamic therapy (PDT) is an approved and widely used treatment for low-risk basal cell carcinoma (BCC), comprising two sessions with an interval of 1 week. Simplification of the treatment course ...